Mawson Infrastructure Group Inc. — Director's Dealing 2018

May 1, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Wize Pharma, Inc. (WIZP)
CIK: 0001218683
Period of Report: 2018-04-04

Reporting Person: Danenberg Noam (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-04-04	Restricted Stock Units (RSUs)	A	40100	—	Acquired	98515	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-04-04	Stock Option (right to buy)	$3.59	A	36000	Acquired	2025-04-04	Common Stock (36000)	Direct

Footnotes

F1: The RSUs were fully vested upon grant.

F2: The RSUs were granted as compensation for services as the COO of the Issuer.

F3: Represents (i) 58,415 shares of the Issuer's Common Stock which are held by Mr. Danenberg through a company where Mr. Danenberg holds a minority interest and he does not serve as a director or an officer and (ii) 40,100 shares of Common Stock which were issued to N. Danenberg Holdings (2000) Ltd., a services company wholly owned by Mr. Danenberg ("Danenberg Holdings"), upon the vesting of RSUs that were granted by the Issuer on April 4, 2018.

F4: The Stock Option is exercisable in twelve equal installments over the three year period from the date of grant.

F5: The Stock Option was granted to Danenberg Holdings as compensation for services as the COO of the Issuer.